{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T09:06:17Z","timestamp":1790931977535,"version":"4.1.0"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Inflammatory infiltrates and endothelial cell proliferation have been appreciated in plexiform and concentric lesions, which characterize the vascular remodeling in primary pulmonary hypertension (PPH). Leukotriene production by perivascular and alveolar macrophages relies on activation of 5-lipoxygenase (5-LO), with translocation of the enzyme to the nuclear membrane, and association with the 5-LO activating protein (FLAP). Using immunohistochemical staining, we localized and semi-quantitatively estimated the abundance of 5-LO and FLAP in lungs obtained from patients with PPH, patients with interstitial lung disease (ILD), and normal control subjects. Expression of 5-LO and FLAP was prominent in alveolar macrophages in both the normal and PPH lungs; however, alveolar macrophages were more frequently clustered in the vicinity of remodeled blood vessel in PPH. Medium- and small-size pulmonary arteries in PPH showed more abundant FLAP expression than in control and ILD lungs. 5-LO expression in small arteries in PPH was more intense than in control and ILD patients. Endothelial cells in plexiform and concentric lesions in PPH expressed both 5-LO and FLAP. In situ hybridization confirmed the presence of 5-LO transcripts in macrophages and endothelial cells of the remodeled vessels in PPH. We propose that the overexpression of 5-LO and FLAP represents evidence for the participation of inflammation in the process of PPH vasculopathy or, alternatively, that the overabundance of the enzymes involved in generation of inflammatory mediators may themselves be related to vascular cell proliferation and cell growth.<\/jats:p>","DOI":"10.1164\/ajrccm.157.1.9704003","type":"journal-article","created":{"date-parts":[[2013,4,4]],"date-time":"2013-04-04T13:30:55Z","timestamp":1365082255000},"page":"219-229","source":"Crossref","is-referenced-by-count":110,"title":["5-Lipoxygenase and 5-Lipoxygenase Activating Protein (FLAP) Immunoreactivity in Lungs from Patients with Primary Pulmonary Hypertension"],"prefix":"10.1093","volume":"157","author":[{"given":"LAUREL","family":"WRIGHT","sequence":"first","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine, Pathology, Pediatric Oncology, and Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RUBIN M.","family":"TUDER","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine, Pathology, Pediatric Oncology, and Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JUN","family":"WANG","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine, Pathology, Pediatric Oncology, and Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CARLYNE D.","family":"COOL","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine, Pathology, Pediatric Oncology, and Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ROBERT A.","family":"LEPLEY","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine, Pathology, Pediatric Oncology, and Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NORBERT F.","family":"VOELKEL","sequence":"additional","affiliation":[{"name":"Division of Pulmonary Sciences and Critical Care Medicine, Departments of Medicine, Pathology, Pediatric Oncology, and Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[1998,1,1]]},"reference":[{"key":"2026032709102442500_B1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1161\/01.CIR.42.6.1163","article-title":"Primary pulmonary hypertension: a pathologic study of the lung vessels in 156 clinically diagnosed cases.","volume":"42","author":"Wagenvoort","year":"1970","journal-title":"Circulation"},{"key":"2026032709102442500_B2","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1159\/000195308","article-title":"Histopathology of primary pulmonary hypertension: a qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry.","volume":"52","author":"Pietra","year":"1987","journal-title":"Respiration"},{"key":"2026032709102442500_B3","first-page":"275","article-title":"Exuberant endothelial cell growth and elements of inflammation are present in plexiform lesions of pulmonary hypertension.","volume":"144","author":"Tuder","year":"1994","journal-title":"Am. J. Pathol."},{"key":"2026032709102442500_B4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1365-2559.1990.tb01054.x","article-title":"The histopathology of 36 cases of plexogenic pulmonary arteriopathy.","volume":"16","author":"Caslin","year":"1990","journal-title":"Histopathology"},{"key":"2026032709102442500_B5"},{"key":"2026032709102442500_B6","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1056\/NEJM199306173282402","article-title":"Expression of endothelin-1 in the lungs of patients with pulmonary hypertension","volume":"328","author":"Giaid","year":"1993","journal-title":"N. Engl. J. Med."},{"key":"2026032709102442500_B7","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1172\/JCI115759","article-title":"Transforming growth factor-B1 is decreased in remodeling hypertensive bovine pulmonary arteries.","volume":"89","author":"Botney","year":"1992","journal-title":"J. Clin. Invest."},{"key":"2026032709102442500_B8","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1172\/JCI117858","article-title":"Increased gene expression for VEGF and VEGF receptors KDR\/Flk and Flt in lungs exposed to acute or chronic hypoxia: modulation of gene expression by nitric oxide.","volume":"95","author":"Tuder","year":"1995","journal-title":"J. Clin. Invest."},{"key":"2026032709102442500_B9","first-page":"37","article-title":"Development of pulmonary arterial changes in rats fed Crotalaria spectabilis.","volume":"94","author":"Meyrick","year":"1979","journal-title":"Am. J. Pathol."},{"key":"2026032709102442500_B10","first-page":"755","article-title":"Pulmonary hypertension induced by repeated pulmonary inflammation in the rat.","volume":"51","author":"Herget","year":"1981","journal-title":"J. Appl. Physiol. Respir. Environ. Exercise Physiol."},{"key":"2026032709102442500_B11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0026-2862(89)90017-4","article-title":"Progressive inflammatory and structural changes in the pulmonary vasculature of monocrotaline-treated rats.","volume":"38","author":"Wilson","year":"1989","journal-title":"Microvasc. Res."},{"key":"2026032709102442500_B12","first-page":"164","article-title":"Repeated Escherichia coli endotoxin-induced pulmonary inflammation causes chronic pulmonary hypertension in sheep: structural and functional changes.","volume":"55","author":"Meyrick","year":"1986","journal-title":"Lab. Invest."},{"key":"2026032709102442500_B13","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1152\/jappl.1992.73.3.1084","article-title":"PAF antagonists inhibit pulmonary vascular remodeling induced by hypobaric hypoxia in rats.","volume":"73","author":"Ono","year":"1992","journal-title":"J. Appl. Physiol."},{"key":"2026032709102442500_B14","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1172\/JCI118696","article-title":"Inhibition of 5-lipoxygenase-activating protein (FLAP) reduces pulmonary vascular reactivity and pulmonary hypertension in hypoxic rats.","volume":"97","author":"Voelkel","year":"1996","journal-title":"J. Clin. Invest."},{"key":"2026032709102442500_B15","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1096\/fasebj.9.11.7649404","article-title":"Specificity of expression and effects of eicosanoid mediators in normal physiology and human diseases.","volume":"9","author":"Goetzl","year":"1995","journal-title":"FASEB J."},{"key":"2026032709102442500_B16","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1146\/annurev.bi.63.070194.002123","article-title":"5-Lipoxygenase.","volume":"63","author":"Ford-Hutchinson","year":"1994","journal-title":"Annu. Rev. Biochem."},{"key":"2026032709102442500_B17","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1126\/science.6301011","article-title":"Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation.","volume":"220","author":"Samuelsson","year":"1983","journal-title":"Science"},{"key":"2026032709102442500_B18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0090-6980(84)90071-6","article-title":"Synthesis of leukotriene B4 and prostanoids by human alveolar macrophages: analysis by gas chromatography\/mass spectrophotometry.","volume":"27","author":"MacDermot","year":"1984","journal-title":"Prostaglandins"},{"key":"2026032709102442500_B19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1165\/ajrcmb.11.2.8049076","article-title":"Increases in 5-lipoxygenase activating protein expression account for enhanced capacity for 5-lipoxygenase metabolism that accompanies differentiation of peripheral blood monocytes into alveolar macrophages","volume":"11","author":"Coffey","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"2026032709102442500_B20","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1172\/JCI117889","article-title":"5-Lipoxygenase is located in the euchromatin of the nucleus in resting human alveolar macrophages and translocates to the nuclear envelope upon cell activation.","volume":"95","author":"Woods","year":"1995","journal-title":"J. Clin. Invest."},{"key":"2026032709102442500_B21","doi-asserted-by":"crossref","first-page":"10980","DOI":"10.1016\/S0021-9258(18)38066-9","article-title":"Translocation of 5-lipoxygenase to the membrane in human leukocytes challenged with ionophore A23187.","volume":"263","author":"Rouzer","year":"1988","journal-title":"Biol. Chem."},{"key":"2026032709102442500_B22","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0021-9258(18)48532-8","article-title":"Membrane association of active 5-lipoxygenase in resting cells: evidence for novel regulation of the enzyme in the rat alveolar macrophage.","volume":"267","author":"Coffey","year":"1992","journal-title":"J. Biol. Chem."},{"key":"2026032709102442500_B23","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1083\/jcb.119.6.1701","article-title":"A23187-induced translocation of 5-lipoxygenase in osteosarcoma cells.","volume":"119","author":"Kargman","year":"1992","journal-title":"J. Cell Biol."},{"key":"2026032709102442500_B24","first-page":"149","article-title":"Methods in laboratory investigation. Immunomax: a maximized immunohistochemical method for the retrieval and enhancement of hidden antigens.","volume":"73","author":"Merz","year":"1995","journal-title":"Lab. Invest."},{"key":"2026032709102442500_B25","first-page":"9","article-title":"Intratumor microvessel density as a prognostic factor in cancer.","volume":"147","author":"Weidner","year":"1995","journal-title":"Am. J. Pathol."},{"key":"2026032709102442500_B26","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1172\/JCI118612","article-title":"Constitutive activation of 5-lipoxygenase in the lungs of patients with idiopathic pulmonary fibrosis.","volume":"97","author":"Wilborn","year":"1996","journal-title":"J. Clin. Invest."},{"key":"2026032709102442500_B27","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM199507273330403","article-title":"Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.","volume":"333","author":"Giaid","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"2026032709102442500_B28","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1073\/pnas.93.11.5241","article-title":"Arachidonate lipoxygenases as essential regulators of cell survival and apoptosis.","volume":"93","author":"Tang","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2026032709102442500_B29","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1172\/JCI118480","article-title":"Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signalling.","volume":"97","author":"Avis","year":"1996","journal-title":"J. Clin. Invest."},{"key":"2026032709102442500_B30","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/0952-3278(93)90224-K","article-title":"Induction of apoptosis in blood cells from a patient with acute myelogenous leukemia by SC41661A, a selective inhibitor of 5-lipoxygenase. Prostaglandin Leukot.","volume":"48","author":"Anderson","year":"1993","journal-title":"Essen. Fatty Acids"},{"key":"2026032709102442500_B31","doi-asserted-by":"crossref","first-page":"24163","DOI":"10.1016\/S0021-9258(19)51063-8","article-title":"5-Lipoxygenase contains a functional Src homology 3-binding motif that interacts with the Src homology 3 domain of Grb2 and cytoskeletal proteins.","volume":"269","author":"Lepley","year":"1994","journal-title":"J. Biol. Chem."}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/157\/1\/219\/67445790\/ajrccm_157_1_219.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/157\/1\/219\/67445790\/ajrccm_157_1_219.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T13:10:33Z","timestamp":1774617033000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/157\/1\/219\/8530976"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1,1]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[1998,1,1]]},"published-print":{"date-parts":[[1998,1,1]]}},"URL":"https:\/\/doi.org\/10.1164\/ajrccm.157.1.9704003","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,1]]},"published":{"date-parts":[[1998,1,1]]}}}